- £18.23bn
- £26.98bn
- £12.49bn
- 85
- 54
- 80
- 87
R2019 March 31st | 2020 March 31st | R2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7,302 | 6,801 | 6,826 | 8,608 | 12,491 |
Cost of Revenue | |||||
Gross Profit | 1,391 | 2,016 | 2,692 | 4,395 | -160 |
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5,688 | 5,835 | 4,170 | 4,850 | 12,637 |
Operating Profit | 1,614 | 966 | 2,656 | 3,759 | -146 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,300 | 588 | 2,418 | 3,482 | -206 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,310 | 466 | 2,194 | 2,599 | -95.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 1,409 | -59 | 2,276 | 3,031 | -84.2 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,409 | -59 | 2,276 | 3,031 | -123 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.319 | 0.645 | 1.13 | 1.43 | 0.407 |
Dividends per Share |